Market Overview The Host Cell Protein (HCP) Testing Market is rapidly growing as biotechnology, pharmaceutical manufacturing, and biologics development continue to expand globally. HCP testing is a critical quality control step used to detect and quantify residual proteins originating from host cells during the production of biologics such as monoclonal antibodies, vaccines, cell therapies,...

Market Overview The Host Cell Protein (HCP) Testing Market is rapidly growing as biotechnology, pharmaceutical manufacturing, and biologics development continue to expand globally. HCP testing is a critical quality control step used to detect and quantify residual proteins originating from host cells during the production of biologics such as monoclonal antibodies, vaccines, cell therapies,...

FBS and Therapeutic Safety: Minimizing Immune Risks Immunogenicity—the risk of triggering immune responses—is a critical concern when using Fetal Bovine Serum (FBS) in therapeutic cell cultures. Even trace bovine proteins can cause patient rejection, limiting FBS use in drug production. By 2026, innovations reducing FBS immunogenicity are making it safer for applications like...

The competitive landscape is defined by both established diagnostic giants and agile biotech startups. A look at the current Non-Alcoholic Steatohepatitis Biomarkers Market Share shows that companies like Siemens Healthineers, Roche, and Abbott are leading the way with their integrated laboratory platforms. However, companies like GENFIT and Labcorp are gaining significant ground through the...